Digicann Ventures（VY3）株式概要デジキャン・ベンチャーズ社は、その子会社とともに大麻業界で事業を展開している。 詳細VY3 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6報酬過去5年間の収益は年間72.1%増加しました。 リスク分析キャッシュランウェイが1年未満である マイナスの株主資本 意味のある時価総額がありません ( €75K )German市場と比較して、過去 3 か月間の株価の変動が非常に大きい+1 さらなるリスクすべてのリスクチェックを見るVY3 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.012該当なし内在価値ディスカウントEst. Revenue$PastFuture-103m15m2016201920222025202620282031Revenue CA$0.002Earnings CA$0.0003AdvancedSet Fair ValueView all narrativesDigicann Ventures Inc. 競合他社TFF PharmaceuticalsSymbol: MUN:0K30Market cap: €9.7mBiofronteraSymbol: XTRA:B8FKMarket cap: €15.1mCantourage GroupSymbol: XTRA:HIGHMarket cap: €76.3mSOL Global InvestmentsSymbol: CNSX:SOLMarket cap: CA$1.1m価格と性能株価の高値、安値、推移の概要Digicann Ventures過去の株価現在の株価CA$0.01252週高値CA$0.02852週安値CA$0.0005ベータ2.261ヶ月の変化200.00%3ヶ月変化140.00%1年変化n/a3年間の変化n/a5年間の変化-99.90%IPOからの変化-99.90%最新ニュースお知らせ • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.お知らせ • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.お知らせ • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.お知らせ • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.最新情報をもっと見るRecent updatesお知らせ • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.お知らせ • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.お知らせ • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.お知らせ • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 01Now 85% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0005. The fair value is estimated to be €0.0034, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Jun 08Agra Ventures Ltd. Appoints Jonathan Hirsh as an Independent Member of the Board of DirectorsAgra Ventures Ltd. announced that Jonathan Hirsh has been appointed as an independent member of the Board of Directors . Best known for his influential work as @Weedstagram416 on the Instagram platform, Jonathan is a globally recognized figure in the cannabis industry, with multiple nominations for the Canadian Cannabis Awards, in both the Influencer of the Year and Cannabis Crusader categories. His impressive portfolio of partnerships comprises over 300 major cannabis-related brands. As a respected voice in the cannabis discourse, Jonathan has journeyed worldwide to judge international cannabis competitions and share his insights at various industry events. Notably, he was among only seven judges invited to participate in the esteemed Jack Herer Cup in Amsterdam. He has also been a guest speaker at CannEx Jamaica in Montego Bay. Jonathan's commitment to cannabis education led him to academia, where he served as a professor of cannabis history at Centennial College. Most recently, he was VP of Marketing and Consumer Experience for Mera Cannabis. There, Jonathan played a pivotal role in developing and launching one of Canada's first legal infused pre-rolls under the Avana and Countryside brands.お知らせ • Jun 03Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023. Location: Suite 810 789 West Pender Street V6C 1H2 Vancouver British Columbia Canadaお知らせ • Jun 01Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh.Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh on March 31, 2023.Agra Ventures Ltd. (CNSX:AGRA) completed the acquisition of Agraflora Europe Gmbh on March 31, 2023.Board Change • Jul 21Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. 3 experienced directors. 4 highly experienced directors. 1 independent director (2 non-independent directors). Member of the Advisory Board C. Rebagliati is the most experienced director on the board, commencing their role in 2007. Independent Director Anthony Carnevale was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Board Change • Jun 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Brian O’Neill was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Jun 04First quarter 2022 earnings released: EPS: CA$0.10 (vs CA$0.29 in 1Q 2021)First quarter 2022 results: EPS: CA$0.10 (down from CA$0.29 in 1Q 2021). Net income: CA$1.42m (down 45% from 1Q 2021).Reported Earnings • May 04Full year 2021 earnings released: CA$0.43 loss per share (vs CA$11.79 loss in FY 2020)Full year 2021 results: CA$0.43 loss per share (up from CA$11.79 loss in FY 2020). Net loss: CA$5.10m (loss narrowed 95% from FY 2020).Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.03 loss per share (up from CA$0.50 loss in 3Q 2020). Net loss: CA$359.4k (loss narrowed 93% from 3Q 2020). Revenue was in line with analyst estimates.Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.30 loss per share (vs CA$0.77 loss in 2Q 2020)Second quarter 2021 results: Net loss: CA$3.58m (loss narrowed 45% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has fallen by 51% per year, which means it is performing significantly worse than earnings.Reported Earnings • Jun 02First quarter 2021 earnings released: EPS CA$0.002 (vs CA$0.009 loss in 1Q 2020)First quarter 2021 results: Net income: CA$2.57m (up CA$11.8m from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 42% per year whereas the company’s share price has fallen by 47% per year.Reported Earnings • May 05Full year 2020 earnings released: CA$0.079 loss per share (vs CA$0.15 loss in FY 2019)Full year 2020 results: Net loss: CA$102.9m (loss widened 1.9% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 40% per year, which means it has not declined as severely as earnings.株主還元VY3DE PharmaceuticalsDE 市場7D200.0%1.9%1.6%1Yn/a26.0%2.2%株主還元を見る業界別リターン: VY3がGerman Pharmaceuticals業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: VY3 German市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is VY3's price volatile compared to industry and market?VY3 volatilityVY3 Average Weekly Movement131.2%Pharmaceuticals Industry Average Movement6.4%Market Average Movement6.0%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.7%安定した株価: VY3の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のVY3のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2004n/aNick Kuzykwww.digicann.ioDigicann Ventures Inc.は、その子会社とともに大麻産業で事業を展開している。大麻製品の生産、販売、流通に従事している。同社は以前Agra Ventures Ltd.として知られていたが、2023年8月にDigicann Ventures Inc.に社名を変更した。デジキャン・ベンチャーズは2004年に法人化され、カナダのバンクーバーに本社を置いている。もっと見るDigicann Ventures Inc. 基礎のまとめDigicann Ventures の収益と売上を時価総額と比較するとどうか。VY3 基礎統計学時価総額€74.78k収益（TTM）-€266.44k売上高(TTM)n/a0.0xP/Sレシオ-0.3xPER（株価収益率VY3 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計VY3 損益計算書（TTM）収益CA$0売上原価CA$0売上総利益CA$0その他の費用CA$428.54k収益-CA$428.54k直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.018グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率-72.0%VY3 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 16:06終値2026/05/27 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Digicann Ventures Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Siddharth RajeevFundamental Research Corp.
お知らせ • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.
お知らせ • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.
お知らせ • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.
お知らせ • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.
Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.
お知らせ • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.
お知らせ • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.
お知らせ • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.
Buy Or Sell Opportunity • Mar 29Now 63% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0065. The fair value is estimated to be €0.018, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 24Now 86% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.002. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 01Now 85% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.0005. The fair value is estimated to be €0.0034, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Jun 08Agra Ventures Ltd. Appoints Jonathan Hirsh as an Independent Member of the Board of DirectorsAgra Ventures Ltd. announced that Jonathan Hirsh has been appointed as an independent member of the Board of Directors . Best known for his influential work as @Weedstagram416 on the Instagram platform, Jonathan is a globally recognized figure in the cannabis industry, with multiple nominations for the Canadian Cannabis Awards, in both the Influencer of the Year and Cannabis Crusader categories. His impressive portfolio of partnerships comprises over 300 major cannabis-related brands. As a respected voice in the cannabis discourse, Jonathan has journeyed worldwide to judge international cannabis competitions and share his insights at various industry events. Notably, he was among only seven judges invited to participate in the esteemed Jack Herer Cup in Amsterdam. He has also been a guest speaker at CannEx Jamaica in Montego Bay. Jonathan's commitment to cannabis education led him to academia, where he served as a professor of cannabis history at Centennial College. Most recently, he was VP of Marketing and Consumer Experience for Mera Cannabis. There, Jonathan played a pivotal role in developing and launching one of Canada's first legal infused pre-rolls under the Avana and Countryside brands.
お知らせ • Jun 03Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023Agra Ventures Ltd., Annual General Meeting, Jul 21, 2023. Location: Suite 810 789 West Pender Street V6C 1H2 Vancouver British Columbia Canada
お知らせ • Jun 01Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh.Agra Ventures Ltd. (CNSX:AGRA) acquired Agraflora Europe Gmbh on March 31, 2023.Agra Ventures Ltd. (CNSX:AGRA) completed the acquisition of Agraflora Europe Gmbh on March 31, 2023.
Board Change • Jul 21Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. 3 experienced directors. 4 highly experienced directors. 1 independent director (2 non-independent directors). Member of the Advisory Board C. Rebagliati is the most experienced director on the board, commencing their role in 2007. Independent Director Anthony Carnevale was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Board Change • Jun 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Brian O’Neill was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jun 04First quarter 2022 earnings released: EPS: CA$0.10 (vs CA$0.29 in 1Q 2021)First quarter 2022 results: EPS: CA$0.10 (down from CA$0.29 in 1Q 2021). Net income: CA$1.42m (down 45% from 1Q 2021).
Reported Earnings • May 04Full year 2021 earnings released: CA$0.43 loss per share (vs CA$11.79 loss in FY 2020)Full year 2021 results: CA$0.43 loss per share (up from CA$11.79 loss in FY 2020). Net loss: CA$5.10m (loss narrowed 95% from FY 2020).
Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.03 loss per share (up from CA$0.50 loss in 3Q 2020). Net loss: CA$359.4k (loss narrowed 93% from 3Q 2020). Revenue was in line with analyst estimates.
Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.30 loss per share (vs CA$0.77 loss in 2Q 2020)Second quarter 2021 results: Net loss: CA$3.58m (loss narrowed 45% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has fallen by 51% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Jun 02First quarter 2021 earnings released: EPS CA$0.002 (vs CA$0.009 loss in 1Q 2020)First quarter 2021 results: Net income: CA$2.57m (up CA$11.8m from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 42% per year whereas the company’s share price has fallen by 47% per year.
Reported Earnings • May 05Full year 2020 earnings released: CA$0.079 loss per share (vs CA$0.15 loss in FY 2019)Full year 2020 results: Net loss: CA$102.9m (loss widened 1.9% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 40% per year, which means it has not declined as severely as earnings.
